These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18270492)

  • 1. Basophil sensitivity in patients not responding to venom immunotherapy.
    Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P
    Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.
    Sturm GJ; Böhm E; Trummer M; Weiglhofer I; Heinemann A; Aberer W
    Allergy; 2004 Oct; 59(10):1110-7. PubMed ID: 15355471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy.
    Eberlein-König B; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2004; 14(1):10-6. PubMed ID: 15160437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
    Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
    Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity of basophils predicts side-effects in venom immunotherapy.
    Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
    Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera venom immunotherapy and field stings.
    Lang R; Hawranek T
    J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results.
    Korosec P; Erzen R; Silar M; Bajrovic N; Kopac P; Kosnik M
    Clin Exp Allergy; 2009 Nov; 39(11):1730-7. PubMed ID: 19689457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.
    Eržen R; Košnik M; Silar M; Korošec P
    Allergy; 2012 Jun; 67(6):822-30. PubMed ID: 22469017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
    Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
    Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
    Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
    Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.
    White KM; England RW
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):426-30. PubMed ID: 18939733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.
    Eberlein-König B; Schmidt-Leidescher C; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2006; 16(1):5-10. PubMed ID: 16599242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil-activation tests in Hymenoptera allergy.
    Dubois AE; van der Heide S
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):346-9. PubMed ID: 17620828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.
    Kucera P; Cvackova M; Hulikova K; Juzova O; Pachl J
    J Investig Allergol Clin Immunol; 2010; 20(2):110-6. PubMed ID: 20461965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
    Goldberg A; Confino-Cohen R; Mekori YA
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.